Determinants of retinal microvascular features and their relationships in two European populations by Kirin, Mirna et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determinants of retinal microvascular features and their
relationships in two European populations
Citation for published version:
Kirin, M, Nagy, R, MacGillivray, T, Polasek, O, Hayward, C, Rudan, I, Campbell, H, Wild, S, Wright, A,
Wilson, J & Vitart, V 2017, 'Determinants of retinal microvascular features and their relationships in two
European populations' Journal of Hypertension. DOI: 10.1097/HJH.0000000000001408
Digital Object Identifier (DOI):
10.1097/HJH.0000000000001408
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Hypertension
Publisher Rights Statement:
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 07. Jul. 2018
CE: Swati; JH-D-17-00071; Total nos of Pages: 14;
JH-D-17-00071
Determinants of retinal microvascular features and
their relationships in two European populations
Mirna Kirina,b, Reka Nagyc, Thomas J. MacGillivrayd, Ozren Polasˇeka,b, Caroline Haywardc,
Igor Rudana, Harry Campbella, Sarah Wilda, Alan F. Wrightc, James F. Wilsona,c, and
Veronique Vitartc
Objectives: To examine factors influencing retinal
vasculature in two environmentally contrasted, cross-
sectional studies of adult participants of European descent
and to estimate the extent and specificity of genetic
contributions to each retinal vasculature feature.
Methods: Retinal images from 1088 participants in the
Orkney Complex Disease Study and 387 in the CROATIA-
Korcˇula study, taken using the same nonmydriatic camera
system and graded by the same person, were evaluated.
Using general linear models, we estimated the influence of
an extensive range of systemic risk factors, calculated
retinal traits heritabilities and genetic correlations.
Main results: Systemic covariates explained little (<4%)
of the variation in vessel tortuosity, substantially more
(>10%, up to 31.7%) of the variation in vessel width and
monofractal dimension. Suggestive not well trodden
associations of biological interest included that of urate,
tissue plasminogen activator and cardiac PR interval with
arteriolar narrowing, that of carotid intima–media
thickness with less-tortuous arterioles and of cardiac QT
interval with more tortuous venules. The genetic
underpinning of tortuosity is largely distinct from that of
the other retinal vascular features, whereas that of fractal
dimension and vessel width greatly overlaps. The previously
recognized influence of ocular axial length on vessel
widths was high and can be expected to lead to
artefactual genetic associations [genetic correlation with
central retinal arteriolar equivalent: 0.53 (standard error
0.11)]. The significant genetic correlation between SBP and
central retinal arteriolar equivalent, 0.53 (standard error
0.22) (after adjusting for age, sex and axial length of the
eye), augurs more favourably for the discovery of genetic
variants relevant to vascular physiology.
Keywords: blood pressure, carotid intima–media
thickness, genetic correlation, heritability, microvascular,
ocular axial length, retinal, urate
Abbreviations: ABPI, ankle–brachial pressure index; AL,
axial length of the eye; AVR, arteriolar-to-venular width
ratio; BP, blood pressure; CIMT, carotid intima–media
thickness; CRAE, central retinal arteriolar equivalent
(average from six vessels); CRP, C-reactive protein; CRVE,
central retinal venular equivalent (average from six vessels);
D0, VAMPIRE software-derived retinal vessels’ multifractal
dimension; Dbox, VAMPIRE software-derived retinal vessels’
monofractal dimension; Df, SIVA software-derived retinal
vessels’ monofractal dimension zone C; Dfv, SIVA software-
derived retinal venular monofractal dimension zone C;
fgluc, fasting glucose; fib, fibrinogen; HbA1c, glycated
haemoglobin A1c; HR, heart rate; PP, pulse pressure; PR,
ECG PR interval, indicator of duration of atrioventricular
conduction; PWA, pulse wave analysis augmentation index;
QT, ECG QT interval, indicator of duration of ventricular
depolarization and repolarization; sua, serum urate level;
TORT, curvature tortuosity; tPA, tissue-type plasminogen
activator; WHR, waist-to-hip ratio
INTRODUCTION
R
etinal vessels are thought to reflect pathological
processes occurring in the less readily accessible
coronary and cerebral microvessels of similar scale
(100–250mm in diameter) [1]. A recent survey of UK
Biobank images reported statistically significant differences
in retinal vessel architecture (higher arteriolar branching
angles and decreased vessel tortuosity) between partici-
pants who had experienced a myocardial infarction and
those who had not [2]. This adds to a long history of
reported epidemiologic associations between retinal vas-
cular features and systemic diseases or risk factors, the
strongest and most widely replicated being that of retinal
arteriole narrowing with hypertension and coronary heart
disease risk [3–6]. Longitudinal studies have reported
associations between baseline measures of arteriolar nar-
rowing and increased incidence of hypertension [7–9], and,
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recently, of atrioventricular conduction abnormalities [10].
These prospective studies underline the importance
of better understanding the determinants of retinal
vascular features as some may be actionable disease
prevention targets. A good understanding of the factors
shaping retinal vessel architecture is however a moving
target as the capture of retinal features is constantly
refined with improving technologies and analysis software
(tortuosity and branching measures are fairly recent
additions), and the list of relevant factors to be explored
is expanding.
Genetic factors are important to gain etiological insights
and provide instruments to test causal relationships, but
genetic research in retinal microcirculation is still not exten-
sive. Several studies have reported the heritabilities of
retinal vessel widths, all indicating substantial genetic influ-
ence on these traits. These include twin studies: a Danish
study of 210 young healthy individuals [11], the Australian
Twins Eye study encompassing 910 twin pairs [12] and
the TwinsUK study encompassing 1463 twin pairs [13].
Heritabilities between 0.56 and 0.70 for central retinal
arteriolar equivalent (CRAE) and 0.62–0.83 for central
retinal venular equivalent (CRVE) were reported. The
TwinsUK study additionally reported high genetic corre-
lation, 0.77, between CRAE and CRVE, predicting genetic
variants affecting both traits to be discovered. Heritabilities
reported in population-based cohorts were lower but still
substantial: 0.48–0.21 for CRAE, 0.54–0.34 for CRVE and
0.38–0.27 for the dimensionless arteriolar-to-venular width
ratio (AVR) in, respectively, the Beaver Dam cohort of
adults aged 43–89 years [14] and a small Flemish popu-
lation-based study (413 participants) [15]. This latter study
reported a genetic correlation between CRAE and CRVE of
0.36, lower than that estimated in the TwinsUK sample, but
still supporting some common genetic determinants in
these traits. The heritabilities of other, nonwidth, retinal
traits are underreported with, to our knowledge, only one
estimate of 0.82 for arteriolar tortuosity in the small Danish
Twins study [16].
Efforts to map genetic determinants for CRAE and CRVE
have already started: through linkage in two studies, with
little overlap of findings [12,17] and more successfully
recently through genome-wide association studies (GWAS)
identifying a total of seven replicated loci influencing
venular width [18,19], two of which were also associated
with arteriolar width [19,20]. One of the CRVE-associated
variants, in ATXN2, has also been associated with SBP and
DBP, but, to our knowledge, the predicted genetic overlap
between retinal microvasculature features and blood pres-
sure (BP) has never been quantified.
Here, using primarily the Orkney Complex Disease
Study (ORCADES) population-based cohort, we aimed to
consolidate basic knowledge on retinal vasculature traits. In
total, seven retinal measures of retinal vessel width,
tortuosity and global pattern of branching were studied
(the latter derived from two different softwares allowing
comparison of measures). Systemic covariates with well
established associations with retinal vessel features, as well
as more sporadically investigated ones, were selected on
the basis of published retinal vessel research. They included
two ocular physical measures; axial length of the eye and
intraocular pressure (IOP); four body shape traits including
stature together with three obesity measures [BMI, waist-to-
hip ratio (WHR) and percentage of body fat (Bodyfat%)];
six cardiovascular traits including SBP, DBP, pulse pres-
sure (PP) and three markers of atherosclerosis [carotid
intima–media thickness (CIMT), the ankle–brachial
pressure index (ABPI) and pulse wave analysis (PWA)
augmentation index]; three quantitative measures of
cardiac physiology that have been little explored pre-
viously; and also 14 blood biochemical markers of inflam-
mation, haemostasis, lipid and glucose metabolism. We
estimated heritability for all retinal traits, investigated the
degree to which these traits are influenced by overlapping
genetic variants and quantified the genetic overlap
between retinal vasculature features and associated
systemic risk factors.
MATERIALS ANDMETHODS
Participants
Orkney is an archipelago in northern Scotland, with a total
population of 20 000 people. ORCADES is a family-based
study comprising 2078 richly phenotyped and genotyped
orcadian participants. Fundus images from 1088 genotyped
individuals were successfully graded. The analysed sample,
with a mean age of 52 years, included 57% women, 3.8%
people with type 2 diabetes and 36.8% hypertensive partici-
pants (52% of whom were taking antihypertensive medi-
cation). Individuals were classified as hypertensive if they
satisfied at least one of these criteria: SBP at least
140 mmHg, or DBP at least 90mmHg or using antihyper-
tensive medication. Some very deep pedigrees were avail-
able. These were verified for genotyped participants and
corrected if necessary using genotype-derived kinship coef-
ficients. After removing uninformative individuals, the ped-
igrees were still too large for analysis; therefore, they were
trimmed to smaller informative pedigrees with a maximum
bitsize of 50 using the software PedCut [21]. In the current
analysis, pairs of closely related individuals with genotypes
and retinal traits comprised 327 parent–child, 286 full sibs,
13 half-sibs, 492 first-degree cousins, 255 avuncular and 31
grandparent–grandchild pairs identified using the software
PEDSTATS [22].
The island of Korcˇula is located in the southern Croatian
coastal region of Dalmatia. A total of 969 individuals were
recruited in this study and most underwent complete eye
examination. Family history data and pedigrees were not
available. Data on numerous quantitative traits associated
with cardiovascular, metabolic and other diseases were also
collected. The eye examination included fundus image
photography, but only 421 images were gradable. Success-
fully graded fundus images from 387 genotyped individuals
were included in the analysis. The analysed sample, with a
mean participant age of 54.3 years, included 68.5% women,
10.6% people with type 2 diabetes and 51.6% hypertensive
participants (44% of whom were taking antihypertensive
medication).
Both studies received approval from the relevant ethics
committees in Scotland and Croatia and complied with the
tenets of the Declaration of Helsinki. All participants were
volunteers and gave written informed consent.
Kirin et al.
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Eye examination and measurements
A high-resolution (12 Mpixel) digital nonmydriatic retinal
camera (CR-DGD; Canon Inc, Utsunomiyashi, Tochigiken,
Japan) was used to capture fundus photographs centred
between the macula and optic disc in participants of the
ORCADES and CROATIA-Korcˇula studies. Retinal fundus
images were obtained at a 458 angle, and all images were
stored in joint photographic experts group or tag image file
format. Images centred overly towards the macula, with
optic disc on the side of the field, were not used in the
image analysis. Furthermore, only retinal images with at
least four major arteries and venules present in the zone of
grading were included. Images of very poor quality (e.g.
out of focus and overexposure of the lens) or from partici-
pants with known disorders influencing image quality (e.g.
cataract and asteroid hyalosis) were also excluded from
the image analysis. Two different software packages were
used for the semiautomated computer-assisted capture of
retinal vessel parameters: VAMPIRE (beta version v2.0), a
platform developed in the Universities of Dundee and
Edinburgh [23] and SIVA (version 3.1) developed at the
National University of Singapore [24]. To ensure the
measures reflected systemic effects and not measurement
or other artefacts specific to one eye, only traits displaying
correlation between left and right eyes of at least 50% were
considered for inclusion in test runs using a subset of
ORCADES images. Subsequently, if both images were of
the same quality, the right eye was chosen for grading,
otherwise the eye with the better photographic quality
was chosen.
Two fractal dimensions derived by the VAMPIRE soft-
ware were analysed: a monofractal dimension (Dbox) cal-
culated using the box-counting technique [25] and a fractal
dimension (D0) from the multifractal spectrum calculated
using the generalized sandbox method [26]. Other
measures showed poor left–right eye correlation and were
therefore deemed unreliable at this stage of software devel-
opment. Fractal measures provide information on the
global geometric complexity (or sparsity) of the retinal
vasculature. The left–right eye correlations were 0.78 for
Dbox and 0.50 for D0, respectively. The VAMPIRE software
automatically segments vessels in the fundus image prior to
fractal analysis.
Vessel calibre measurements, tortuosity measurements,
branching parameters and fractal dimensions were also
derived using the SIVA software. In total, 30 traits were
examined (Supplementary Table 1, http://links.lww.com/
HJH/A778). Here again, branching parameters did not meet
the left–right eye correlation criteria and were therefore not
pursued further. The SIVA software supports automatic
optic disc grid placement and vessel tracking and typing
(venules or arterioles). These annotations were checked
and improved manually by the grader. Two different areas
of the fundus image are used to visualize vessel traits; areas
are between 0.5 and 1 disc diameter away from the per-
imeter of the optic disk (zone B) and between 0.5 and 2 disc
diameters (extended zone). Vessel calibre measurements
are image magnification-correction-dependent. In the cur-
rent analysis, the same calibration factor (ratio of
micrometers per pixel) was applied to all pictures. It was
obtained by dividing the average vertical height of the
optic disc (in pixels) in 10% of the retinal images in the
study population obtained with the SIVA software by
the assumed average optic disc diameter (1800mm: the
published average for white participants [27]).
In total, 12 traits derived from SIVA were retained: CRAE
and CRVE vessel width measurements (following the
method developed by Knudtson et al. [28]), their dimen-
sionless ratio, AVR, calculated from zone B and the
extended zone (six traits); curvature tortuosity (TORT)
measures [29] pertaining to arterioles (a), venules (v) or
all vessels (t) (three traits); and monofractal dimensions (Df)
for all vessels or venules only (two traits) based on a
curvature-based segmentation method [30].
A set of 60 images from a Singapore Research Eye Study
were used to calculate intergrader reliability (i.e. two differ-
ent graders analysing the same sets of images). For intra-
observer reliability assessment (i.e. the same grader at
different times), 60 images from the ORCADES study were
used. Intraclass correlation coefficient was used as a
measure of reliability. Results (Supplementary Table 2,
http://links.lww.com/HJH/A778) confirmed previously
published results of high reliability for these quantitative
retinal vessel trait measurements.
In total, 1109 images from Orkney and 421 from Korcˇula,
scored using SIVA and/or VAMPIRE softwares, by one
grader (M.K.), were used in this analysis.
Measurement of cardiovascular risk factors
Total and HDL cholesterol, triglycerides and urate [serum
urate level (sua)] were measured in serum; C-reactive
protein (CRP) and fasting glucose were measured in ethyl-
enediaminetetraacetic acid (EDTA) plasma; fibrinogen and
tissue-type plasminogen activator (tPA) were measured in
citrated plasma; and glycated haemoglobin A1c was
measured in whole blood in EDTA. LDL cholesterol levels
were calculated using the Friedewald equation.
ABPI is the ratio of the BP in the lower leg to the BP in the
arm. The measurements used in the analysis were calcu-
lated as the lowest posterior tibial (ankle) SBP divided by
the highest brachial SBP.
Augmentation index was the only trait selected from
PWA. PWA was performed after 1 h of supine rest. Radial
arterial tonometry was performed using the SphygmoCor
Px system (AtCor Medical, Sydney, New South Wales,
Australia) with a Miller tonometer (Miller Instruments,
Houston, Texas, USA) continuously for 30 s in a resting
state, and an average waveform was generated. Four read-
ings were performed in total (two successful readings
followed by 5min rest followed by two further readings).
The augmentation index is a ratio calculated from the PP
waveform and one of the most commonly used noninvasive
measures of arterial stiffness. It is defined as the ratio of
augmentation pressure to PP. The stiffer the arteries, the
more quickly the reflected pressure wave travels and is
superimposed on the forward wave, thus augmenting
the pressure.
CIMT was assessed by ultrasound examination of the
common carotid artery 2 cm below the carotid bifurcation.
The mean of three measurements was used as a final trait in
the analysis. This measure was only available in the
ORCADES study.
Factors influencing retinal microvasculature
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SBPs and DBPs were measured twice using digital
sphygmomanometers (OMRON Healthcare,Hoofddorp,
The Netherlands) and the second measurements were used
in analysis as continuous variables, without correction for
medication taken. Smoking information was collected
(categorized as current, former or never smoked) through
questionnaires. Bodyfat% in ORCADES was measured
using bioimpedance with Tanita scales. Bodyfat% in
CROATIA-Korcˇula was calculated from four skin folds
measurements using Harpenden skin callipers. Linear
regression equations were used to calculate body density
[31], and Siri’s function [32] was used to calculate Bodyfat%.
Electrocardiogram (ECG)-derived measures included
QT, the interval reflecting duration of ventricular depolar-
ization and repolarization; PR, the interval reflecting the
duration of atrioventricular conduction; and RR, the interval
between two ventricular contractions in milliseconds. Heart
rate (HR) in beats per minute was derived as 60 000/RR.
Digital 10-s ECGs were taken after at least 10min of supine
rest, using a computer link with QT and RR intervals
calculated using CardioView software (NUMED Cardiac
Diagnostics, Sheffield, UK). QT was corrected for HR, using
the Bazett’s formula QTc ¼ QTﬃﬃﬃﬃ
RR
p .
Genotyping and quality control
DNA was extracted from peripheral blood. Extraction was
done using BACC3 Nucleon kits (GE Healthcare Life
Sciences, Little Chalfont, Buckinghamshire, UK) by the
WTCRF (Wellcome Trust Clinical Research Facility, Western
General Hospital, Edinburgh, UK) for ORCADES and at the
Medical School, University of Split for CROATIA-Korcˇula
participants. Participants were genotyped using dense
single nucleotide polymorphism (SNP) arrays: a mix of
the Illumina HumanHap300v2, 370CNV-Quad beadchips
(n¼ 890), the Illumina Omni1 (n¼ 304) and Illumina
OmniExpress beadchips (n¼ 1073) for ORCADES and
370CNV-Duo and Quad beadchips for Korcˇula, following
the manufacturer’s standard recommendations. Genotypes
were determined using the Illumina BeadStudio or Genome
Studio (Hap/Omni) softwares. Analysis using genotype
data in ORCADES were performed on the common set of
markers across the three arrays used.
Genotyping rates for both SNPs and individuals were
checked using the GenABEL package implemented in R
(http://www.r-project.org). Individuals with less than 97%
genotyping rate were removed from further analysis. SNPs
with call rate below 98% and P value for Fisher’s exact test
of Hardy–Weinberg equilibrium below 10–6 were also
removed. In addition, samples with excess autosomal het-
erozygosity or sex inconsistency were removed because of
possible sample contamination or mix up. Ethnic outliers
were removed on the basis of principal components
analysis of genotypic data. After these quality control steps,
the number of genotyped individuals available with retinal
trait measures was 1088 for Orcades and 387 for Korcˇula.
Statistical analyses
General linear models
Descriptive statistics and tests were performed using R
(http://www.r-project.org). Normality of distributions of
retinal traits was tested using the Kolmogorov–Smirnov
normality test (lillie.test) implemented in the nortest pack-
age in R, in addition to graphical representation of each trait
distribution. Traits for which the distribution of residuals
strongly deviated from normality (after adjusting for stand-
ard covariates) were transformed using quantile normal-
ization using the rntransform () function of the GenABEL R
package [33].
A first pass to select relevant covariates for each retinal
trait was done using Spearman phenotypic correlations on
raw data using the rcorr() function of the Hmisc R package.
Based on this exploratory analysis, best predictors (those
displaying rank correlations with retinal traits significant at
the 0.01 level) were fitted singly and together within full
linear mixed models to get unbiased estimates of their
effects and to evaluate confounding. We additionally
examined the effect of sex and smoking coded as ever/
never smoked. The mixed linear models were fitted using
the polygenic function in GenABEL, taking family structure
into account as a random effect with a genetic relationship
matrix calculated in GenABEL using the gkin function.
Confounding between effects was tested first by fitting
multipredictors incrementally within functionally similar
groups of covariates, then across functional groups reject-
ing from the final model the predictors that did not provide
a better fit than a model not including them as ascertained
by the Bayesian information criteria (BIC). The mixed linear
models also provided heritability estimates for the study
traits, accounting for the effects of the influential covariates.
Genetic correlations
Genetic correlations (together with trait heritabilities) were
calculated for the ORCADES study for which extended
pedigree information was available, using the SOLAR
software (version 7.6.4) [34]. Bivariate analyses were
performed to partition the phenotypic correlation
between the two traits (rp) into genetic (rg) and environ-
mental (re) correlations according to the equation
rP¼ rgHh12Hh22þ reH(1h12)H(1h22), where h12and
h2
2correspond to the heritability of traits 1 and 2, respec-
tively, and were calculated using a variance component
framework [35].
RESULTS
Retinal traits descriptive statistics
Summary descriptive statistics for the 13 retinal vessel
features measured with confidence (refer to the
‘MATERIALS AND METHODS’ section) are displayed in
Supplementary Table 3, http://links.lww.com/HJH/A778,
for numbers of participants with whole-genome genotypes
in the ORCADES and CROATIA-Korcˇula cohorts. Measures
were comparable in the two populations. Many of these 13
retinal traits were highly correlated (Supplementary Table
4, http://links.lww.com/HJH/A778): the vessel widths
measured in the zone B only or in the extended zone C,
the tortuosity for arterial-only and all vessels measures and
the monofractal and multifractal dimensions measured by
the VAMPIRE software. Width and tortuosity were the least
correlated pairs of traits: venular tortuosity measures dis-
played no significant relationship with vessel width and
Kirin et al.
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arteriolar tortuosity some significant but low-level corre-
lations (highest Pearson phenotypic correlations, rp¼ 16%
with CRAE, rp¼ 11% with CRVE). The vascular monofractal
dimensions measured by the VAMPIRE and SIVA softwares,
respectively, Dbox and Df, were significantly but not totally
positively correlated (50%). They similarly captured cova-
riations with vessel tortuosity (rp ranging from 17 to 26% for
Dbox and 25 to 31% forDf), butDbox captured more of vessel
width features (rP¼ 38% with CRAE and 43% with CRVE)
than Df (rP¼ 10% with CRAE and 15% with CRVE).
Further exploration of these traits was narrowed to the
subset of seven not too highly correlated (rp lower than
75%) traits.
Association between retinal traits and systemic
measures
Pairwise phenotypic correlations
An exploratory scan for covariates influencing the seven
retinal vasculature measures was performed in the largest
dataset, ORCADES, using rank correlations of raw trait
values. The strength and significance of correlations with
the physical measures are given in Table 1 and for the
biochemical measures in Supplementary Table 5, http://
links.lww.com/HJH/A778. Venular tortuosity was the trait
that was least modulated by these covariates; in contrast,
monofractal dimension measured by the VAMPIRE soft-
ware displayed correlations with almost every covariate
examined. TORTv was not influenced by age or BP, which
were major determinants of all other retinal features. The
covariates most strongly associated with TORTv were axial
length of the eye (rP¼12%; the shorter the eye, the
greater the venular tortuosity) and cardiac QT interval
(9%; the longer the interval, the greater the tortuosity).
Both venular and arteriolar vessel widths were strongly
associated with ocular axial length; their ratio, AVR, TORTa
and monofractal dimensions were not. Generally, all retinal
traits negatively correlated with BP (i.e. all traits but TORTv)
were also negatively correlated with PWA, CIMT, two
markers of atherosclerosis and usually QTc and PR inter-
vals, markers of, respectively, ventricular depolarization
and repolarization and atrioventricular depolarization
and conduction. Venular width (CRVE) showed no influ-
ence of obesity measures and little influence of the bio-
chemical variates examined, whereas all the other retinal
traits influenced by BP did. The low positive correlation
(significant at the nominal 0.05 level) between venular
width and cortisol may however be of note for further
investigation, as CRVE was the only retinal trait together
withDbox to be associated with cortisol. Arteriolar measures
(purely arteriolar: CRAE, TORTa or composite: Df and
Dbox), the most strongly correlated with BP, CIMT and
TABLE 1. Phenotypic correlations with nonretinal ocular and cardiovascular physical parameters in the Orkney Complex Disease Study
sample
CRAE CRVE AVR TORTa TORTv Df Dbox
Age S0.3a
NU1088
S0.22a
NU1088
S0.09a
NU 1088
S0.16a
NU 1088
0.04
N¼1088
S0.29a
NU1088
S0.51a
NU745
IOP 0.02
N¼514
0.07
N¼514
0.08
N¼514
0.08
N¼514
0.1b
N¼514
0
N¼514
0
N¼413
AL S0.34a
NU550
S0.28a
NU550
0.07
N¼550
0.06
N¼550
S0.12a
NU 550
0
N¼550
0.09
N¼446
Height 0.04
N¼1085
0.08b
N¼1085
0.02
N¼1085
0.02
N¼1085
0.03
N¼1085
0.05
N¼1085
0.14a
N¼745
WHR 0.17a
NU1085
0.05
N¼1085
S0.15a
NU 1085
0.07b
N¼1085
0.01
N¼1085
S0.09a
NU1085
S0.15a
NU745
Bodyfat S0.12a
NU1080
0.02
N¼1080
S0.12a
NU 1080
0.06
N¼1080
0.07b
N¼1080
0.07b
N¼1080
0.15a
NU745
BMI S0.14a
NU1085
0
N¼1085
S0.16a
NU 1085
0.06b
N¼1085
0.07b
N¼1085
S0.08a
NU1085
S0.15a
NU745
SBP S0.37a
NU1084
S0.15a
NU1084
S0.24a
NU 1084
S0.12a
NU 1084
0.04
N¼1084
S0.27a
NU1084
S0.37a
NU745
DBP S0.3a
NU1084
0.06b
N¼1084
S0.25a
NU 1084
0.06b
N¼1084
0.03
N¼1084
S0.16a
NU1084
S0.25a
NU745
PP S0.28a
NU1084
S0.15a
NU1084
S0.14a
NU 1084
S0.11a
NU 1084
0.05
N¼1084
S0.25a
NU1084
S0.32a
NU745
ABPI 0.06
N¼804
0.01
N¼804
0.07b
N¼804
0
N¼804
0.05
N¼804
0.05
N¼804
0.04
N¼745
PWA S0.25a
NU546
S0.2a
NU546
0.07
N¼546
S0.13a
NU 546
0.02
N¼546
S0.27a
NU546
S0.39a
NU501
CIMT S0.19a
NU1076
S0.1a
NU1076
S0.1a
NU 1076
S0.1a
NU 1076
0.03
N¼1076
S0.2a
NU1076
S0.33a
NU741
HR 0.06
N¼1067
0.04
N¼1067
S0.11a
NU 1067
0.02
N¼1067
0.02
N¼1067
0.01
N¼1067
0.01
N¼729
QTc S0.15a
NU1084
0.08b
N¼1084
0.07b
N¼1084
0.03
N¼1084
0.09a
NU 1084
S0.09a
NU1084
S0.21a
NU744
PR S0.12a
NU1049
0.07b
N¼1049
0.06
N¼1049
S0.08a
NU 1049
0.02
N¼1049
0.08b
N¼1049
S0.16a
NU717
Spearman correlation based on raw data, aand bold denote different from 0 at 0.01 significance threshold, bat 0.05 significance threshold, no annotation denotes not significantly
different from 0. CRAE CRVE and AVR, central retina arterioles, venules widths and ratio of in vessels from the B zone; TORT arteriolar (a) and venular(v) tortuosity; Df and Dbox global
retinal vasculature pattern captured by monofractal dimension calculated using respectively the SIVA and the VAMPIRE softwares. ABPI, ankle–brachial pressure index; AL, axial length;
AVR, arteriolar to venular width ratio; CIMT, carotid intima–media thickness; CRAE, central retinal arteriolar equivalent; CRVE, central retinal arteriolar equivalent; HR, heart rate; IOP,
intraocular pressure; PP, pulse pressure; PWA, pulse wave analysis; TORT, curvature tortuosity; WHR, waist to hip ratio.
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PWA, all displayed significant associations with tPA and
sua: two biochemical cardiovascular risk markers. The ABPI
stood out amongst the BP measures as having little associ-
ation with any of the retinal traits. Similarly, amongst the
biochemical measures, the cholesterol measures did not
display strong associations.
Multivariate analyses
The effects of the best predictors based on this analysis,
together with sex and smoking, their confounding, the most
parsimonious models explaining the maximum amount of
retinal trait variation and the heritability estimates for the
retinal traits after adjustments for these covariates, are listed
in Table 2.
For CRAE, the small but significantly negative associations
with several cardiovascular biochemical markers (tPA, fast-
ing glucose, serum urate, triglycerides and insulin – each
explaining 1–2% of the phenotypic variance) were found to
be largely explained by the clustering of these factors. The
best fittingpredictor in this categoryof covariateswas tPAbut
fewer individuals had this trait measured. In the absence of a
tPA measurement, circulating suawas the strongest predictor
in this category. Amongst thephysicalmeasures pertaining to
systemic blood flow, which were more strongly associated
with CRAE, the effects of arterial stiffness and atherosclerotic
markers, PWA and CIMT, and cardiac health, PR and QT
intervals did not add significantly to the strong effects
already accounted for by SBP and DBP. Amongst the
body-shape traits, all three measures, BMI, WHR and Body-
fat%, contributed somewhat independently, although when
age and sex were added to the model, the combination of
Bodyfat and BMI alone was sufficient. Ocular length was,
together with BP, a major, independent predictor of the
CRAE variation, whereas neither body shape nor bio-
chemical markers (tPA or sua) contributed substantially
when SBP was accounted for, as assessed by BIC. Thus,
the more parsimonious final model for CRAE included age,
SBPandDBP, which together accounted for 16%of the initial
CRAE variation, whereas axial length explained an extra 16%
of the variation in CRAE.
Similarly, no biochemical measures were independently
associated with the other retinal traits in the final multi-
variate models – most of their effects were confounded by
the SBP effect – except for insulin in the AVR model. Sex
was not a significant cofactor for any of the traits, and
smoking only contributed to the final models for CRVE and
AVR. Amongst the haemodynamic and atheroma measures,
only CIMT surpassed the SBP effect for arteriolar tortuosity.
Obesity measures were not retained in any of the final
models. CRAE, CRVE and Dbox were the retinal traits that
most associated with systemic covariates, which accounted,
respectively, for 31.7, 15.7 and 26.9% of their variance, with
axial length a major source of variation for the former two
and age for Dbox. Tortuosity traits, arteriolar and venular,
were the least associated with systemic covariates, these
accounting for, respectively, 3.7 and 2% of their variation.
Heritability of the traits adjusted for the covariates ranged
from 21.1% for Df to 57% for CRVE (when axial length is
accounted for, together with age and smoking).
The strongest effects observed in ORCADES, those of
age, axial length and BP, had similar magnitude in the
independent study of CROATIA-Korcˇula. In ORCADES
and CROATIA-Korcˇula, respectively, age explained 8.9–
9.2% of Df variance and 25.6–16.47% of Dbox, whereas SBP
explained 13.8–6.6%, DBP 9.6–6.7% and axial length 14.1–
6.8% of the measured variation in CRAE. Fitting models in
the small CROATIA-Korcˇula sample for vessel widths and
tortuosity measures using the covariates and factors
selected in ORCADES led to similar conclusions regarding
confounding and the ranking of effects (Supplementary
Table 6, http://links.lww.com/HJH/A778). The sua effect
on CRAE was stronger in CROATIA-Korcˇula and remained
significant after accounting for SBP (the effect of which was
lower in CROATIA-Korcˇula than in ORCADES) and the
effect of insulin on AVR seen in ORCADES replaced by
an effect of sua (effect of which was confounded with
insulin in ORCADES). Unfortunately, two novel associ-
ations described in ORCADES, CIMT and TORTa, tPA
and CRAE, could not be tested in CROATIA-Korcˇula in
which these measures were not available. There were also
TABLE 3. Effect of blood pressure increase of 10mmHg on age adjusted retinal calibre depending on hypertensive status
Study Trait
Non hypertensive Hypertensive (med/nomed) All
N Effect SE P value N Effect SE P value N Effect SE P value
SBP CROATIA-Korcˇula CRAE 183 2.28 0.9 0.0126 195
(110/85)
0.47
(0.23/0.9)
0.53
(0.78/0.79)
0.373
(0.77/0.25)
378 1.3 0.33 0.00012
CRVE 0.26 1.26 0.84 1
(1.64/0.15)
0.71
(1.02/1.11)
0.16
(0.11/0.89)
378 0.75 0.45 0.103
ORCADES CRAE 686 2.31 0.39 4.60109 398
(189/209)
1.58
(1.18/ 2.28)
0.32
(0.46/0.53)
1.1106
(0.012/3.8105)
1084 1.74 0.2 3.041018
CRVE 0.4 0.56 0.47 1.56
(1.52/1.85)
0.47
(0.71/0.75)
0.001
(0.035/0.015)
1084 0.51 0.29 0.0804
DBP CROATIA-Korcˇula CRAE 183 2.24 1.3 0.0873 195
(110/85)
2.24
(2.42/2.04)
0.9
(1.48/1.16)
0.017
(0.108/0.08)
378 2.89 0.64 1.08105
CRVE 0.78 1.81 0.665 1.33
(3.4/1.01)
1.27
(1.95/1.63)
0.295
(0.083/0.54)
378 1.07 0.88 0.228
ORCADES CRAE 686 2.79 0.54 3.64107 398
(189/209)
2.23
(2.23/2.15)
0.53
(0.88/0.72)
3.3105
(0.012/0.0034)
1084 2.8 0.34 8.731016
CRVE 0.05 0.54 0.92 0.7
(0.79/0.96)
1.34
(1.39/1.01)
0.6
(0.57/0.34)
1084 0.19 0.49 0.698
med, taking antihypertensive medication; N, number of study participants; nomed, not taking antihypertensive medication; CRAE, central retinal arteriolar equivalent; CRVE, central
retinal venular equivalent; ORCADES, Orkney Complex Disease Study. P values are denoted with  and  for respectively a 5% and 1% significance threshold.
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too few ECG data for the individuals with retinal images in
Korcula (N¼ 157) to include them in the modelling of best
predictors; however, Spearman correlations (Supple-
mentary Table 7, http://links.lww.com/HJH/A778) of CRAE
with PR and TORTv with QTc were in agreement with that
observed in ORCADES, respectively, 0.11 (P¼ 0.17) and
0.12 (P¼ 0.14).
Modulation of effects depending on hypertensive
status
The lower effect of SBP on CRAE in CROATIA-Korcˇula may
be partly explained by a higher proportion of hypertensive
patients in this population (51.6% compared with 36.8% in
ORCADES – Supplementary Table 8, http://links.lww.com/
HJH/A778). Effects of SBP on CRAE after stratifying the
samples by hypertensive status were explored (Table 3),
confirming a trend for an apparent reduced effect of SBP on
CRAE in hypertensive individuals; this seems mainly driven
by antihypertensive medication intake (Table 3). In con-
trast, the narrowing effect of DBP on CRAE was unaffected
by hypertensive status (and medication). Table 3 addition-
ally highlights that for CRVE, the weak, narrowing effect of
a BP increase (SBP and DBP) appears strengthened in
hypertensive individuals (in medicated individuals only
in CROATIA-Korcˇula, independent of medication intake
in ORCADES).
Genetic contributions
Heritabilities of all retinal traits adjusted for age and sex and
their genetic correlations in the ORCADES study are reported
in Table 4. Strong positive genetic correlations were found
between arterial and venular parameters: width [rg¼ 0.69,
standard error (SE)¼ 0.10] and TORT (rg¼ 0.59, SE¼ 0.15),
suggesting a substantial portion of common genetics under-
lying vessel anatomy. These remained strong after further
adjustment for SBP (displayed in the lower triangular matrix
of Table 4) and the additional adjustment for axial length for
CRAE and CRVE (rg¼ 0.74, SE¼ 0.12). Monofractal dimen-
sion derived from the VAMPIRE software, Dbox, showed
100% genetic correlation with that measured by SIVA, Df,
and shared common genetic determinants with the vessel
calibres (rg¼ 0.77, SE¼ 0.21 with CRAE; rg¼ 0.47, SE¼ 0.18
with CRVE; all adjusted for SBP). The tortuosity measures
displayed significant heritabilities, 0.55 (SE¼ 0.08) for arte-
rioles and 0.21 (SE¼ 0.07) for venules (traits adjusted for age
and sex, Table 4), but their underlying genetic determinants
are largely expected to be distinct from those influencing
width or fractal dimensions [strongest genetic correlation
0.34 (SE¼ 0.19) between venular width and tortuosity; the
strongest with arteriolar tortuosity was 0.29 (SE¼ 0.17)
with AVR].
Genetic correlations between retinal traits and the most
important systemic risk factors were calculated (Supple-
mentary Table 9, http://links.lww.com/HJH/A778). Genetic
correlations between CRAE as well as CRVE and axial length
of the eye were high and highly significant, whereas genetic
correlations between CRAE and SBP or DBP were low but
strengthened and reached significance after adjusting for
axial length of the eye. The genetic correlation between
SBP and CRAE was then 0.53 (SE 0.22, P¼ 0.025), and the
genetic correlation between CRAE and DBP was 0.37 (SE
0.19, P¼ 0.06), quantifying the expected contribution of
shared genetic determinants to both arteriolar vessel widths
and BP. These values remained unchanged after adjusting
vessel widths for hypertensive medication effect (not
shown). The genetic correlations for the other pairs of traits
investigated, including CRVE and SBP, were low and NS in
the sample analysed.
DISCUSSION
The influence of a range of cardiovascular and ocular
factors on retinal traits examined in two population-based
samples was found to replicate and extend previous
reports. Our studies were relatively small and therefore
only identify strong-to-moderate effects conclusively. Fail-
ing to investigate in great details the role of treatment is also
a limitation of the study. High levels of relatedness in the
population-based ORCADES sample allowed us to system-
atically quantify genetic correlations among retinal traits
and associated systemic traits, providing novel information
on their underlying common causes.
TABLE 4. Retinal trait heritability and genetic correlation estimates in the Orkney Complex Disease Study
Trait CRAE CRVE AVR TORTa TORTv Dfv Dbox
CRAE 0.32 (0.07)
PU 9T 10S7
0.69 (0.10)
PU1.23T10–5
NC 0.11 (0.14)
P¼0.43
0.18 (0.2)
P¼0.4
0.78 (0.33)
PU0.003
0.79 (0.2)
PU 0.0006
CRVE 0.71 (0.10)
PU 1.22T10S5
0.43 (0.07)
PU1.23T10–9
0.57 (0.12)
P¼0.002
0.09 (0.12)
P¼0.46
0.34 (0.19)
P¼0.07
0.72 (0.26)
PU0.002
0.46 (0.17)
PU 0.024
AVR 0.13 (0.19)
P¼0.55
S0.61 (0.11)
PU0.001
0.27 (0.08)
PU2.2T10–4
0.29 (0.17)
P¼0.06
0.24 (0.25)
P¼0.33
0.06 (0.29)
P¼0.83
0.14 (0.26)
P¼0.58
TORTa 0.13 (0.14)
P¼0.33
0.08 (0.12)
P¼0.52
S0.32 (0.17)
PU0.05
0.55 (0.08)
PU2.2T10–13
0.59 (0.15)
PU0.0005
0.13 (021)
P¼0.55
0.17 (0.17)
P¼0.34
TORTv 0.17 (0.20)
P¼0.41
0.33 (0.19)
P¼0.07
0.26 (0.25)
P¼0.28
0.60 (0.15)
PU0.0003
0.21 (0.07)
PU0.0007
0.26 (0.29)
P¼0.4
0.09 (0.26)
P¼0.73
Dfv 0.76 (0.44)
PU 0.005
0.72 (0.26)
PU0.002
0.16 (0.3)
P¼0.6
0.11 (0.21)
P¼0.62
0.28 (0.29)
P¼0.37
0.15 (0.08)
PU0.028
1
PU 10–4
Dbox 0.77 (0.21)
PU 0.001
0.47 (0.18)
PU0.02
0.09 (0.26)
P¼0.72
0.16 (0.17)
P¼0.38
0.09 (0.26)
P¼0.74
1
PU1.7T 10S4
0.22 (0.09)
PU 0.0037
Heritabilities of trait adjusted for age and sex are displayed on the diagonal, the corresponding genetic correlations above the diagonal, and the genetic correlations for traits
additionally adjusted for SBP under the diagonal. Estimates nominally significantly different from zero (5% significance threshold) are displayed in bold. AVR, arteriolar to venular width
ratio; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; Dbox, VAMPIRE software derived retinal vessels, monofractal dimension; Df, SIVA software-
derived retinal vessels, monofractal dimension zone C; NC, not converging to stable estimate; TORT, curvature tortuosity.
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Hypertension-associated markers and retinal
trait measures
Df and CRAE have been reported as the traits with the
strongest association with BP in a Malay population [36],
as observed here in ORCADES for Df, CRAE and Dbox
(phenotypic correlation with Df¼ 55%). In combination,
BP and age explained 11, 16 and 27% of the interindividual
variation, for, respectively, Df, CRAE and Dbox.
SBP effects on age-adjusted retinal vessel widths in
Korcˇula (1.3mm CRAE, 0.75mm CRVE decrease per
10-mmHg SBP increase) and Orkney (1.74mm CRAE,
0.5mm CRVE decrease per 10-mmHg SBP increase)
(Table 3) are in agreement with effects in two other older
adult population-based cohorts (1.1–1.9mm for CRAE,
0.2–0.5mm for CRVE [37,38]). DBP effects in Korcˇula
(2.9mm CRAE, 1.1mm CRVE decrease per 10-mmHg DBP
increase) and Orkney (2.8mm CRAE, 0.2mm CRVE decrease
per 10-mmHg DBP increase) were also comparable with
published reports (2.1–4.3mm CRAE and 0.7–0.8mm CRVE
[37,38]).
The phenotypic correlations between retinal arterial
width and markers relating to BP and macrovascular health
(SBP and DBP, PP, PWA and CIMT) were all strongly
negative, in line with the well established association
between high BP and retinal arteriolar narrowing. A more
novel finding is the negative association between atrioven-
tricular conduction time (PR) and CRAE, which is in line
with the reported association of lower CRAE at baseline and
incidence of atrioventricular conduction anomalies (PR
interval>200 ms) in the multiethnic study of atherosclerosis
(MESA) prospective study [10], as well as the reported
positive association between arterial stiffness, a feature
associated with arteriolar narrowing, and PR interval [39].
Although in the MESA study, CRAE predicted PR independ-
ently of BP, in our smaller sized cross-sectional studies, the
PR association was confounded with that of SBP, and
replication of an association between arteriolar narrowing
and myocardial health independent of BP will require
larger studies.
All venular measures and the arteriolar tortuosity
measures were less influenced by BP or showed no
relationship. Of note, however, the influence of BP on
CRVE was stronger in both our studies in hypertensive
individuals, and the negative association of SBP with CRVE
reached statistical significance in the largest sample,
ORCADES, when the analysis was restricted to hypertensive
individuals. This stronger effect was found in all hyper-
tensive ORCADES participants regardless of them taking
antihypertensive medications. A different magnitude of
effect of SBP (not DBP) on CRAE was also observed
between hypertensive and nonhypertensive subgroups,
but this was more clearly modulated by antihypertensive
medications intake and compatible with the reported dilat-
ing effect on CRAE of several antihypertensive treatments
[40,41].
The role of markers of macrovascular atherosclerosis to
better understand variation in microvasculature has not
been studied extensively. PWA, SBP and PP have been
correlated to wall-to-lumen ratio of retinal arterioles, with
PP found to be the best independent predictor (above SBP
and PWA) [42]. CIMT, which estimates the extent of athero-
sclerosis in the carotid artery, has been previously reported
to be significantly associated with CRAE and AVR in the
large population-based Rotterdam Study [38], and its effect
was partly independent from the BP measurements. When
significant, the effects of PP, PWA and CIMT were con-
founded with those of SBP and/or DBP in the ORCADES
analyses, probably due to the limited power to detect true
small effects above those of BP in this smaller study. The
notable exceptions, however, were in modelling TORTa
andDf, not studied in [38], in which CIMT contributed to the
trait variation beyond the effect accounted for by SBP,
although for Df, the CIMT effect was confounded with
age. These findings agree with tortuosity and fractal dimen-
sion being sensitive indicators of retinal blood flow. CIMT
was not measured in CROATIA-Korcˇula, and the suggested
novel association of this atherosclerotic marker with retinal
arteriolar tortuosity should be replicated. Different markers
of atherosclerosis, carotid plaque score and ABPI were
found to be positively associated with CRVE in the Rotter-
dam study in which these associations persisted after adjust-
ment for BP [38] but we were unable to replicate these
findings in our studies, the former measure being unavail-
able and the latter not found to be strongly correlated
with CRVE.
The significant genetic correlations between SBP and
CRAE (after adjusting for age, sex and ocular axial length)
underline substantial common genetic determinants to
these traits. This is in line with the evidence that the earliest
manifestation of cardiovascular disease occurs in the micro-
circulation. Most changes to the retinal microvasculature
are caused by haemodynamic changes and oxygen satur-
ation associated with elevated BP. A few prospective stud-
ies have also presented evidence that narrowing of the
arteriolar calibre precedes the development of hyperten-
sion [7–9], supporting the hypothesis that it is an integral
part in the development of cardiovascular disease. Only
two loci have been associated with CRAE so far, MEF2C [20]
and OCA2 [19], neither of which were amongst the signifi-
cant loci associated with BP in a very large GWAS [43];
however, those are predicted to have small effect sizes, and
shared loci would likely only be found when a similar very
large study is assembled for retinal traits. Utilizing corre-
lated traits in multivariate analyses offers a way to boost
power in GWAS studies [44], and our discovery of genetic
correlation between retinal calibre and SBP makes it a
promising avenue of investigation to target the fraction
of genetic variants also influencing BP.
Biochemical markers and retinal trait measures
When individually correlated with retinal traits, most bio-
chemical markers were confounded by SBP or DBP in our
studies (with it being impossible to infer the direction of
causality). There is no systematic finding of replicated
robust association of blood biomarkers with retinal traits
like there is for BP in the literature, and independence of
effects, subject to the covariates being tested together. In
agreement with Cheung et al. [45], we found no significant
effect of lipid levels, glucose and CRP beyond age, BP and
refraction for monofractal dimensions in the ORCADES
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study. Although quantitatively contributing little to the
variation of retinal traits, serum urate level, a covariate
not explored extensively, seemed to contribute to CRAE
and AVR over and above BP and BMI in CROATIA-Korcˇula
(but was confounded with other covariate effects in
ORCADES), which is interesting given the complex
relationship between urate and cardiovascular risk [46].
To our knowledge, only two previous studies have
examined the association between sua and retinal traits.
In a Chinese urban sample of 869 participants more than
40 years old [47], hyperuricaemia was associated with
arteriolar narrowing, as observed in our studies, and ven-
ular widening, and remained so after adjustments for dys-
lipidaemia, central obesity, hypertension and smoking
status. In the recent study of CRAE, CRVE and Df in 2169
healthy Han Chinese individuals [48], sua was significantly
positively correlated with CRVE, but not with CRAE, and
this association remained after adjustments for BP, smoking
status, alcohol consumption, triglyceride levels, CRP levels
and CRAE. Clearly, the role of sua, a modifiable factor,
would benefit from further investigation in larger studies as
it has plausible modes of independent action, for example
via its effect on nitric oxide-mediated endothelial-depend-
ent vasodilatation, and complex opposing outcomes:
restoring [49] or attenuating [50] endothelial function,
possibly depending on oxidative stress status.
Ocular parameters and retinal trait measures
Axial length was the major explanatory variable for CRAE
and CRVE in both ORCADES and CROATIA-Korcˇula,
explaining 6.8–14% of the trait variation. This association
has been noted previously [51,52] and has been shown to
disappear when correcting for ocular magnification [53],
reflecting the effect of ocular dimension on the image size
(fitting with the direction of the association: smaller eye,
apparently larger calibres). Correcting for magnification is
however not always straightforward. Rudnicka et al. [54]
showed that several Canon fundus camera models are of
nontelecentric construction so that a nonuniform magnifi-
cation correction needs to be applied, depending on degree
of ametropia. The choice of the fundus camera and mag-
nification correction applied will therefore induce a large
source of variation between studies, with nonbiological
source of variation more important in some studies than
others. Retinal vessel calibre studies ideally should there-
fore adjust for axial length of the eye measured. In the
ORCADES study, adjusting for axial length increased the
strength of the genetic correlation between CRAE and SBP
to reach statistical significance, despite a smaller sample
size (as axial length was not available for all samples). The
high genetic correlations between axial length and CRAE
and CRVE likely do not represent true common genetic
causes, offering a sobering warning for interpretation of
genetic correlations. The recent novel association of an
OCA2 pigmentation gene variant with CRAE and CRVE [19]
may similarly quite possibly be due to the influence of eye
colour on these retinal trait measurements [55] rather than
an underlying cause. The dimensionless ratio, AVR, has
been advocated to circumvent the magnification noise [52]
but as a ratio it does not capture the same information as the
individual components. As expected, it was not influenced
by axial length of the eye in our studies, nor were the fractal
dimension measures. A small but significant fraction (2%) of
the variability in venular tortuosity, a retinal trait not influ-
enced by any other study covariates, was attributable to
axial length variation both in ORCADES and CROATIA-
Korcˇula (longer eye associated with less tortuosity). Myopia
has previously been associated with less-tortuous arterio-
les, increased vessel (both arterioles and venules) branch-
ing coefficients [51] and higher Df [45]. These may represent
true biological associations as these measures are dimen-
sionless and blood flow has been shown to be reduced in
myopic eyes in the Singapore Malay Eye Study report
[45,56].
There was no strong association of IOP with any of the
retinal traits, in agreement with published findings for
retinal vascular calibres [57,58] and Df [45].
Genetic determinants of retinal traits
Heritability estimates of retinal vessel traits calculated in
ORCADES showed low-to-medium but significant genetic
contribution to interindividual variabilities for all the
retinal traits.
Vessel width
Vessel width heritability estimates (CRAE 0.32, CRVE 0.43,
age-adjusted and sex-adjusted) were in line with published
population-based estimates and, as previously observed
lower than the twin study estimates, in agreement with
the fact that twin-based studies provide an upper limit
heritability estimate. A general consistent trend across the
various studies is that of higher heritabilities for venular
width, compared with arterial, which is possibly reflected in
the higher GWAS success for CRVE than CRAE so far. This
would agree with haemodynamic and metabolic changes,
of possible large environmental component, influencing
arterioles more than venules. Heritability estimates for AVR
(ratio of arterial and vein diameters) were very similar
across studies (ORCADES 0.27, Beaver Dam study 0.38,
Flemish population-based study 0.27). This perhaps is not
surprising as AVR gives a ratio of the two widths and is
therefore devoid of across-study noise common to both
measurements (e.g. ocular magnification). CRAE and CRVE
displayed both high phenotypic (rp) and genetic (rg)
correlations (rP¼ 0.53, rg¼ 0.69; age-adjusted and sex-
adjusted traits), in line with twin data estimates
(rP¼ 0.55, rg¼ 0.65–0.77 [13]) and higher than results
reported in the Flemish study (rg¼ 0.36). The Flemish study
only included 413 participants randomly selected from 70
families [15], presenting a less genetically informative
sample than the isolated population of Orkney. The genetic
correlation between CRAE and CRVE remains high after
additional adjustment for SBP (rg¼ 0.71) or ocular axial
length [rg¼ 0.74 (SE¼ 0.12)], confirming common genetic
factors shaping both arterioles and veins, independently of
BP (and axial length), and in agreement with the first CRAE
GWAS hit described, close to the MEF2C gene, also influ-
encing CRVE [20].
Vessel tortuosity and fractal dimensions
Taarnhoj et al. [16] reported very high heritability for
arteriolar tortuosity (h2¼ 0.82); however, this was a twin
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study and included only 218 participants. We estimated the
heritability of arterial TORT to be 55% in ORCADES, the
highest amongst the retinal traits analysed. The trait was not
influenced by the axial length of the eye but was associated
by CIMT, independently of age, reflecting modulation by
atheromatous processes in the arterial wall. Venular tor-
tuosity heritability was lower (h2 close to 21%), possibly due
to a thinner vessel wall that is more responsive to systemic
changes, compared with the wall of the arterioles. Venular
tortuosity was inversely associated with ocular axial length,
and positively with QTc, a marker of myocardial health. The
effect of age on arteriolar but not venular tortuosity is in line
with the generally stronger effect of age on arteriolar
compared with venular retinal traits. It could be in part
due to the inherent alteration of elastin with age, which is
more abundant in the arterioles, contributing to age-
dependent rigidification [59]. Despite different heritability
and associations with systemic covariates, venular and
arteriolar curvature tortuosities shared common genetic
determinants, based on their high genetic correlations
(rg¼ 0.59, SE¼ 0.15). The low genetic correlations
between tortuosity and width or fractal dimension traits,
on the other hand, suggest little common causes. No
reported data on the genetic contribution to the variance
of fractal dimensions exist, and this study represents the first
report of this trait’s heritability. Monofractal measures from
VAMPIRE (Dbox) and SIVA (Df) had similar low heritability,
close to 22%, and high genetic correlation highlighting a
good agreement between the two methods. This suggests
that meta-analysis of genetic effects on data generated using
the two different softwares can be carried out to maximise
sample size. Monofractal dimensions shared genetic deter-
minants with the vessel calibres, to a bigger extent than
AVR, and as they were not associated with axial length may
be very practical measures to use in genetic association
meta-analyses. The venular component, Dfv, displayed the
lowest and least significant heritability (h2¼ 0.15).
In conclusion, our study reinforced some features of
retinal trait genetic architecture that have been described in
other studies and discovered some novel features worthy of
further investigation when large dataset will be available.
The estimates of heritability and genetic correlations
suggest genetics to be a fruitful area of investigation. These
analyses should help to guide and interpret future genetics
studies, a long-term goal of which is to better understand
the nature of the relationship between retinal features and
cardiovascular outcomes.
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Reviewers’ Summary Evaluations
Reviewer 1
The paper examines in two cross sectional European
studies the influence on retinal vessel characteristics of
several systemic covariates. As expected, age and systolic
blood pressure were associated with dimension and vessel
widths. The Authors also underlined a significant genetic
correlation between systolic blood pressure and central
retinal equivalent. A limit of the paper is failing to inves-
tigate the important role of treatment.
Reviewer 2
This study evaluated 1088 retinal images from two cross-
sectional studies. Systemic covariates explained little of the
variation in vessel tortuosity and venular monofractal
dimension but substantially more (>10%, up to 31.7%) of
the variation in total monofractal dimension and vessel
widths. Some genetic correlations between arteriolar and
venular features were present.
Since fractal dimensions in the retinal network have
been proved to be associated with clinical events (Liew
G, et al. Fractal analysis of retinal microvasculature and
coronary heart disease mortality. Eur Heart J 2011; 32:422–
429), the study, although not completely novel, provides
interesting information.
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